Overview

Parathyroid Hormone for the Treatment of Humerus Fractures

Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
0
Participant gender:
All
Summary
Hypothesis: The investigators want to study whether parathyroid hormone improves healing of humerus after a fracture. The investigators will assess healing of the humerus with Constant score.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hvidovre University Hospital
Collaborator:
Takeda
Treatments:
Hormones
Parathyroid Hormone
Criteria
Inclusion Criteria:

- proximal humeral fracture eligible for conservative treatment.

- able to understand the protocol

- signs an informed consent

Exclusion Criteria:

- liver disease

- kidney disease

- severe osteoporosis

- malignant disease

- bone metabolic disease

- oral treatment with bisphosphonates during the last 3 months.

- treatment with Denosumab during the last 6 months.

- intravenous treatment with bisphosphonates during the last 12 months.